IP Library Patent Application 11490543
Patent Application
App. No. 11/490,543

Process for the production of 3-oxo-pregn-4-ene-21, 17-carbolactones by the metal-free oxidation of 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanes

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/490,543
Abstract

This invention relates to processes for the production of 3-oxo-pregnane-21,17-carbolactones of formula II as well as 3-oxo-pregn-4-ene-21,17-carbolactones of formula III by the metal-free oxidation of 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanes of formula I In addition, the invention relates to the dichioromethane hemisolvate of 6β,7β;15β,16β-dimethylene-3-oxo-17α-pregnan-5β-ol-21,17-carbolactone (IV) as such as well as to a process for the production of drospirenone.

Claims (113)

1 . Process for the production of 3-oxo-pregnane-21,17-carbolactones of formula II

in which

R 5 is hydrogen, hydroxy;

R 6a is hydrogen, together with R 5 a double bond, or together with R 7a a —CH 2 group;

R 6b is hydrogen, together with R 7b a —CH 2 group or a double bond;

R 7a is hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl, C 1 -C 4 -thioacyl or together with R 6a a —CH 2 group,

R 7b is hydrogen, or together with R 6b a —CH 2 group;

R 9 is hydrogen, together with R 11 a double bond, or together with R 11 an epoxy group -O-;

R 10 is hydrogen, methyl, or ethyl;

R 11 is hydrogen, together with R 9 a double bond or together with R 9 an epoxy group -O-;

R 13 is hydrogen, methyl or ethyl;

R 15 is hydrogen, C 1 -C 4 -alkyl, together with R 16 a —CH 2 group or a double bond;

R 16 is hydrogen, together with R 15 a —CH 2 group or a double bond;

comprising the reaction of compounds of formula I

with at least 3 molar equivalents of an organic or inorganic hypochlorite as oxidizing agent in the presence of catalytic amounts of a 2,2,6,6-tetramethylpiperidine -N-oxide derivative at a pH of at least 8.0.

2 . Process according to claim 1 for the production of 3-oxo-17α-pregnane-21,17-carbolactones of formula IIa

in which

R 6a is hydrogen or together with R 7a a —CH 2 group:

R 6b is hydrogen, together with R 7b a —CH 2 group, or a double bond;

R 7a is hydrogen, C 1 -C 4 -alkoxycarbonyl, or C 1 -C 4 -thioacyl;

R 7b is hydrogen, or together with R 6b a —CH 2 group,

R 9 is hydrogen, together with R 11 a double bond or together with R 11 an epoxy group —O—;

R 10 is hydrogen, or methyl;

R 11 is hydrogen, together with R 9 a double bond or together with R 9 an epoxy group -O-;

R 15 is hydrogen, together with R 16 a —CH 2 group or a double bond;

R 16 is hydrogen, together with R 15 a —CH 2 group or a double bond;

wherein compounds of formula Ia

are reacted.

3 . Process according to claim 1 for the production of the compound of formula IIb,

whereby the compound of formula Ib

is used as a starting material.

4 . Process for the production of 3-oxo-pregn-4-ene-21,17-carbolactones of formula III

in which

R 6a is hydrogen, together with R 5 a double bond, or together with R 7a a —CH 2 group;

R 6b is hydrogen, together with R 7b a —CH 2 group or a double bond;

R 7a is hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl, C 1 -C 4 -thioacyl or together with R 6a a —CH 2 group,

R 7b is hydrogen, or together with R 6b a —CH 2 group;

R 9 is hydrogen, together with R 11 a double bond, or together with R 11 an epoxy group -O-;

R 10 is hydrogen, methyl, or ethyl;

R 11 is hydrogen, together with R 9 a double bond or together with R 9 an epoxy group -O-;

R 13 is hydrogen, methyl or ethyl;

R 15 is hydrogen, C 1 -C 4 -alkyl, together with R 16 a —CH 2 group or a double bond,

R 16 is hydrogen, together with R 15 a —CH 2 group or a double bond; comprising the following steps:

a) the reaction of compounds of general formula I

in which

R 5 is hydroxy;

R 6a , R 6b , R 7a , R 7b , R 10 , R 11 , R 13 , R 15 , R 16 have the same meaning as in formula III,

with at least 3 molar equivalents of an organic or inorganic hypochlorite as an oxidizing agent in the presence of 1-5mol % of a 2,2,6,6-tetramethyl-piperidine-N-oxide derivative at a pH of at least 8.0 and at a temperature of 0-15° C., in dichloromethane or in a two-phase dichloromethane-water mixture,

to form the compounds of formula II

b) subsequent elimination of water at pH<5, optionally in the presence of an acid.

5 . Process for the production of 3-oxo-pregn-4-ene-21,17-carbolactones of formula III

in which

R 6a is hydrogen, together with R 5 a double bond, or together with R 7a a —CH 2 group;

R 6b is hydrogen, together with R 7b a —CH 2 group or a double bond;

R 7a is hydrogen, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxycarbonyl, C 1 -C 4 -thioacyl or together with R 6a a —CH 2 group,

R 7b is hydrogen, or together with R 6b a —CH 2 group; R 9 is hydrogen, together with R 11 a double bond, or together with R 11 an epoxy group -O-;

R 10 is hydrogen, methyl, or ethyl;

R 11 is hydrogen, together with R 9 a double bond or together with R 9 an epoxy group —O—;

R 13 is hydrogen, methyl or ethyl;

R 15 is hydrogen, C 1 -C 4 -alkyl, together with R 16 a —CH 2 group or a double bond,

R 16 is hydrogen, together with R 15 a —CH 2 group or a double bond;

comprising the following steps:

a) the reaction of compounds of general formula I

in which

R 5 is hydroxy;

R 6a , R 6b , R 7a , R 7b , R 10 , R 11 , R 13 , R 15 , R 16 have the same meaning as in formula III, with at least 3 molar equivalents of an organic or inorganic hypochlorite as an oxidizing agent in the presence of catalytic amounts of a 2,2,6,6-tetramethyl-piperidine-N-oxide derivative at a pH of at least 8.0, in dichloromethane or in a two-phase dichloromethane-water mixture;

to form the compounds of formula II

b) the isolation of compounds of formula II

c) subsequent elimination of water at pH<5, optionally in the presence of an acid.

6 . Process according to claim 4 for the production of 3-oxo-17α-pregn-4-ene-21,17-carbolactones of formula IIa

in which

R 6a is hydrogen or together with R 7a a —CH 2 group;

R 6b is hydrogen, together with R 7b a —CH 2 group, or a double bond;

R 7a is hydrogen, C 1 -C 4 -alkoxycarbonyl, or C 1 -C 4 -thioacyl;

R 7b is hydrogen, or together with R 6b a —CH 2 group,

R 9 is hydrogen, together with R 11 a double bond or together with R 11 an epoxy group -O-;

R 10 is hydrogen, or methyl;

R 11 is hydrogen, together with R 9 a double bond or together with R 9 an epoxy group -O-;

R 15 is hydrogen, together with R 16 a —CH 2 group or a double bond;

R 16 is hydrogen, together with R 15 a —CH 2 group or a double bond,

wherein the compounds of formula Ia

are reacted.

7 . Process according to claim 4 for the production of a compound of formula IIIb

whereby the compound of formula Ib

is used as a starting material.

8 . Process for the production of dichloromethane hemisolvate IV:

comprising the following steps:

a) the reaction of compounds of general formula Ib

with at least 3 molar equivalents of an organic or inorganic hypochlorite as an oxidizing agent in the presence of catalytic amounts of a 2,2,6,6-tetramethyl-piperidine-N-oxide derivative at a pH of at least 8.0, in dichloromethane or in a two-phase dichloromethane-water mixture;

b) the isolation of compounds of formula II

9 . Process according to claim 5 , wherein 1-5 mol % of the 2,2,6,6-tetramethylpiperidine-N-oxide derivative is used.

10 . Process according to claim 5 , wherein 1-1.5 mol % of 2,2,6,6-tetramethylpiperidine-N-oxide is used.

11 . Process according to claim 1 , wherein 3-6 molar equivalents of alkali hypochlorite are used.

12 . Process according to claim 1 , wherein 3-4 molar equivalents of sodium hypochlorite are used.

13 . Process according to claim 1 , wherein the pH of the reaction solution is between 8.5 and 10.0.

14 . Process according to claim 1 , wherein the pH of the reaction solution is set with potassium bicarbonate.

15 . Process according to claim 1 , wherein the reaction temperature is 0 to 15° C.

16 . Process according to claim 1 , wherein after the oxidation reaction is completed, a reducing agent for quenching excess hypochlorite reagent is added to the reaction mixture.

17 . Process according to claim 16 , wherein the reducing agent is added with the addition of a base or a basic buffer at a pH of more than 5.

18 . Process according to claim 16 , wherein an aqueous alkali hydrogen sulfite solution is used as a reducing agent.

19 . Process according to claim 16 , wherein as a reducing agent, sodium hydrogen sulfite or potassium hydrogen sulfite is used in the form of the aqueous solution of sodium disulfite or potassium disulfite.

20 . Process according to claim 17 , wherein sodium phosphate (Na 3 PO 4 ) is used as a base or a basic buffer.

21 . 6β,7β; 15β, 16β-dimethylene-3-oxo-17α-pregnan-5β-ol-21,17-carbolactone-dichloromethane hemisolvate.

22 . Process for the production of drospirenone comprising reacting 6β,7β; 15β, 16β-dimethylene-3-oxo-17α-pregnan-5β-ol-21,17-carbolactone-dichloromethane hemisolvate with an acid.

23 . Process according to claim 22 , wherein the acid is sulfuric acid, hydrochloric acid or para-toluenesulfonic acid.

24 . The compound of claim 21 in isolated form.

25 . The process of claim 22 wherein said hemisolvate was previously isolated.

26 . The process of claim 1 further comprising isolating said compound of formula II.

27 . The process of claim 2 further comprising isolating said compound of formula IIa.

28 . The process of claim 3 further comprising isolating said compound of formula IIb.

29 . A process of claim 1 wherein said number of molar equivalents is 3.0-3.5.

30 . A process of claim 4 wherein said number of molar equivalents is 3.0-3.5.

31 . A process of claim 5 wherein said number of molar equivalents is 3.0-3.5.

Assignments (3)
CHANGE OF NAME Recorded Jul 12, 2011
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 026579/0001 →
CHANGE OF NAME Recorded Nov 14, 2007
From: SCHERING AKTIENGESELLSCHAFT
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 020110/0334 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 13, 2006
From: SEILZ, CARSTEN; SEBA, HARTMUT
To: SCHERING AG
Reel/Frame 018593/0905 →